$ROIV
Roivant Sciences Ltd.

2023 Q4 Form 10-Q Financial Statement

#000114036123052721 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $37.14M $37.10M
YoY Change 117.8% 196.03%
Cost Of Revenue $3.668M $3.270M
YoY Change 2.29% -10.19%
Gross Profit $33.47M $33.84M
YoY Change 148.57% 280.57%
Gross Profit Margin 90.12% 91.21%
Selling, General & Admin $197.3M $164.4M
YoY Change 17.25% 4.24%
% of Gross Profit 589.39% 485.68%
Research & Development $123.7M $132.0M
YoY Change -1.45% -0.01%
% of Gross Profit 369.61% 390.02%
Depreciation & Amortization $5.411M $5.600M
YoY Change 5.05% -27.77%
% of Gross Profit 16.17% 16.55%
Operating Expenses $324.7M $313.6M
YoY Change -17.83% 6.91%
Operating Profit $5.061B -$276.5M
YoY Change -1438.59% -1.54%
Interest Expense $9.444M $9.247M
YoY Change -65.97% -116.13%
% of Operating Profit 0.19%
Other Income/Expense, Net $34.74M -$5.931M
YoY Change 74.61% -31.15%
Pretax Income $5.098B -$327.4M
YoY Change -1434.37% 4.34%
Income Tax $25.67M $3.757M
% Of Pretax Income 0.5%
Net Earnings $5.096B -$304.3M
YoY Change -1547.72% 4.37%
Net Earnings / Revenue 13721.55% -820.27%
Basic Earnings Per Share $6.37 -$0.40
Diluted Earnings Per Share $6.03 -$0.40
COMMON SHARES
Basic Shares Outstanding 803.9M 771.7M
Diluted Shares Outstanding 844.5M 770.2M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.671B $1.408B
YoY Change 336.73% -11.93%
Cash & Equivalents $6.671B $1.408B
Short-Term Investments
Other Short-Term Assets $135.9M $143.4M
YoY Change 14.42% 28.21%
Inventory $5.240M $4.905M
Prepaid Expenses $52.64M $60.72M
Receivables $41.08M $52.10M
Other Receivables $3.209M $2.500M
Total Short-Term Assets $6.807B $1.552B
YoY Change 313.47% -9.52%
LONG-TERM ASSETS
Property, Plant & Equipment $21.86M $24.48M
YoY Change -41.39% -37.51%
Goodwill
YoY Change
Intangibles $150.4M $140.6M
YoY Change 2.95% 0.23%
Long-Term Investments $239.9M $250.4M
YoY Change -11.94% 1.54%
Other Assets $46.85M $49.80M
YoY Change 1.35% 319.37%
Total Long-Term Assets $505.9M $513.9M
YoY Change -9.12% 2.65%
TOTAL ASSETS
Total Short-Term Assets $6.807B $1.552B
Total Long-Term Assets $505.9M $513.9M
Total Assets $7.313B $2.066B
YoY Change 231.95% -6.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $35.23M $44.12M
YoY Change -26.61% 6.69%
Accrued Expenses $122.1M $152.9M
YoY Change -7.71% 18.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $45.71M $49.00M
YoY Change 21.16% 37.04%
Total Short-Term Liabilities $244.9M $265.5M
YoY Change 0.26% 15.08%
LONG-TERM LIABILITIES
Long-Term Debt $403.3M $389.4M
YoY Change 7.52% 3.55%
Other Long-Term Liabilities $4.428M $5.175M
YoY Change -79.38% -43.16%
Total Long-Term Liabilities $4.428M $5.175M
YoY Change -79.38% -43.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $244.9M $265.5M
Total Long-Term Liabilities $4.428M $5.175M
Total Liabilities $728.1M $739.9M
YoY Change -6.15% 5.49%
SHAREHOLDERS EQUITY
Retained Earnings $727.3M -$4.400B
YoY Change -119.66% 29.9%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.090B $948.5M
YoY Change
Total Liabilities & Shareholders Equity $7.313B $2.066B
YoY Change 231.95% -6.77%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $5.096B -$304.3M
YoY Change -1547.72% 4.37%
Depreciation, Depletion And Amortization $5.411M $5.600M
YoY Change 5.05% -27.77%
Cash From Operating Activities -$210.4M -$196.5M
YoY Change -5.47% 3.62%
INVESTING ACTIVITIES
Capital Expenditures $333.0K $300.0K
YoY Change -34.45% -109.67%
Acquisitions
YoY Change
Other Investing Activities $5.233B -$36.20M
YoY Change -174373.33% -74.82%
Cash From Investing Activities $5.233B -$36.40M
YoY Change -149145.71% -75.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 236.7M 207.8M
YoY Change 53.2% -2930.68%
NET CHANGE
Cash From Operating Activities -210.4M -196.5M
Cash From Investing Activities 5.233B -36.40M
Cash From Financing Activities 236.7M 207.8M
Net Change In Cash 5.259B -25.10M
YoY Change -7444.43% -92.7%
FREE CASH FLOW
Cash From Operating Activities -$210.4M -$196.5M
Capital Expenditures $333.0K $300.0K
Free Cash Flow -$210.7M -$196.8M
YoY Change -5.54% 5.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1676813000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
121774000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-79225000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39086000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
48629000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
53251000
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
250393000
CY2023Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
304317000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
144881000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49796000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49482000
CY2023Q3 us-gaap Assets
Assets
2065543000
CY2023Q1 us-gaap Assets
Assets
2389604000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
44123000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
37830000
CY2023Q1 roiv Liability Instruments Measured At Fair Value
LiabilityInstrumentsMeasuredAtFairValue
63546000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48630000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53476000
CY2023Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
188911000
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
180700000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5320503000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4933137000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4368897000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3772754000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3072000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2617000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
948534000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1157766000
CY2023Q3 us-gaap Minority Interest
MinorityInterest
377099000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2065543000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2389604000
CY2023Q3 roiv Operating Costs
OperatingCosts
3266000
CY2022Q3 roiv Operating Costs
OperatingCosts
3641000
roiv Operating Costs
OperatingCosts
7480000
roiv Operating Costs
OperatingCosts
5367000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
131984000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
131995000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
257117000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
267825000
CY2023Q3 roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
13950000
CY2022Q3 roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
0
roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
26450000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
164355000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
157663000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
320545000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
306735000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
313555000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
293299000
us-gaap Operating Expenses
OperatingExpenses
611592000
us-gaap Operating Expenses
OperatingExpenses
579927000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-280766000
us-gaap Operating Income Loss
OperatingIncomeLoss
-552867000
us-gaap Operating Income Loss
OperatingIncomeLoss
-563075000
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-45849000
CY2023Q3 roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-21533000
CY2022Q3 roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
13541000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-76045000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-27672000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5931000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5950000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2165000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5509000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6164000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-331118000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-315921000
us-gaap Profit Loss
ProfitLoss
-658963000
us-gaap Profit Loss
ProfitLoss
-669705000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-26791000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-62820000
us-gaap Net Income Loss
NetIncomeLoss
-596143000
us-gaap Net Income Loss
NetIncomeLoss
-623399000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
0
us-gaap Gain Loss On Investments
GainLossOnInvestments
-53413000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
152923000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
167129000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10903000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11693000
CY2023Q3 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
28120000
CY2023Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
26940000
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
48998000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
40720000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8599000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15076000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
272448000
CY2023Q3 roiv Liability Instruments Measured At Fair Value
LiabilityInstrumentsMeasuredAtFairValue
31114000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
389445000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
375515000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
760143393
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
760143393
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
0
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2023Q1 us-gaap Minority Interest
MinorityInterest
449821000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1325633000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1607587000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5295000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8716000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
26279000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
30219000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
10142000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
6774000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12390000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1447000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4154000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4753000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-14566000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-9173000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-446359000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-441712000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
678000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10560000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-511000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36346000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-154311000
roiv Proceeds From Subsidiary Debt Financings Net
ProceedsFromSubsidiaryDebtFinancingsNet
0
roiv Proceeds From Subsidiary Debt Financings Net
ProceedsFromSubsidiaryDebtFinancingsNet
159899000
roiv Repayment Of Long Term Debt And Convertible Debt By Subsidiary
RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary
14471000
roiv Repayment Of Long Term Debt And Convertible Debt By Subsidiary
RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary
14685000
roiv Payment For Offering And Loan Costs
PaymentForOfferingAndLoanCosts
0
roiv Payment For Offering And Loan Costs
PaymentForOfferingAndLoanCosts
2250000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
907000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
roiv Payments Of Taxes For The Repurchase Of Equity
PaymentsOfTaxesForTheRepurchaseOfEquity
5788000
roiv Payments Of Taxes For The Repurchase Of Equity
PaymentsOfTaxesForTheRepurchaseOfEquity
8329000
roiv Noncash Other
NoncashOther
33000
roiv Noncash Other
NoncashOther
691000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001635088
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1408231000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
143396000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1551627000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1798587000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24477000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
140621000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
265546000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5175000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17032000
CY2023Q3 us-gaap Liabilities
Liabilities
739910000
CY2023Q1 us-gaap Liabilities
Liabilities
782017000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000000341740141
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000000341740141
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
800792365
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
800792365
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37101000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12533000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58725000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16852000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-276454000
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-54678000
CY2023Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
17354000
CY2022Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
16762000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
17354000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
16762000
CY2023Q3 roiv Interest Income
InterestIncome
14299000
CY2022Q3 roiv Interest Income
InterestIncome
5670000
roiv Interest Income
InterestIncome
31014000
roiv Interest Income
InterestIncome
7651000
CY2023Q3 us-gaap Interest Expense
InterestExpense
9247000
CY2022Q3 us-gaap Interest Expense
InterestExpense
8335000
us-gaap Interest Expense
InterestExpense
18159000
us-gaap Interest Expense
InterestExpense
10947000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1338000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7035000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-327361000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-313756000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-653454000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-663541000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3757000
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-24331000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-46306000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-304327000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-291590000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
770227849
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
770227849
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
699888061
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
699888061
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
764780630
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
764780630
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
697894414
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
697894414
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-331118000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-315921000
us-gaap Profit Loss
ProfitLoss
-658963000
us-gaap Profit Loss
ProfitLoss
-669705000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3602000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3752000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-546000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
9519000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3602000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3752000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-546000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9519000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-327516000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-312169000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-659509000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-660186000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-26727000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-24648000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-62911000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-46822000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-300789000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-287521000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-596598000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-613364000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1607587000
CY2023Q2 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans Net Of Forfeitures And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansNetOfForfeituresAndTaxWithholdingPayments
-14395000
CY2023Q2 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
890000
CY2023Q2 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2023Q2 roiv Dividend Declared By Subsidiary
DividendDeclaredBySubsidiary
6000000
CY2023Q2 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
49260000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4148000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-327845000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1334139000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
199822000
CY2023Q3 roiv Stock Issued During Period Value Common Share Related To Settlement Of Warrants Value
StockIssuedDuringPeriodValueCommonShareRelatedToSettlementOfWarrantsValue
83264000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
587000
CY2023Q3 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans Net Of Forfeitures And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansNetOfForfeituresAndTaxWithholdingPayments
-20873000
CY2023Q3 roiv Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
35050000
CY2023Q3 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
196000
CY2023Q3 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2023Q3 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
49318000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3602000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-331118000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1325633000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2038943000
CY2022Q2 roiv Issuance Of Subsidiary Common Shares To The Company Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyValue
0
CY2022Q2 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans Net Of Forfeitures And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansNetOfForfeituresAndTaxWithholdingPayments
8329000
CY2022Q2 roiv Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration
StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration
0
CY2022Q2 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
72794000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
5767000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-353784000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1755391000
CY2022Q3 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlans
0
CY2022Q3 roiv Stock Issued During Period Common Shares And Other Consideration For Acquisition Value
StockIssuedDuringPeriodCommonSharesAndOtherConsiderationForAcquisitionValue
8948000
CY2022Q3 roiv Issuance Of Subsidiary Common Shares To The Company And Capital Contributions To Subsidiaries
IssuanceOfSubsidiaryCommonSharesToTheCompanyAndCapitalContributionsToSubsidiaries
0
CY2022Q3 roiv Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
0
CY2022Q3 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
61979000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3752000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-315921000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1514149000
us-gaap Profit Loss
ProfitLoss
-658963000
us-gaap Profit Loss
ProfitLoss
-669705000
us-gaap Share Based Compensation
ShareBasedCompensation
98578000
us-gaap Share Based Compensation
ShareBasedCompensation
134773000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-53413000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-79225000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-76045000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-27672000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
17354000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
16762000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11426000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7753000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3316000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4194000
roiv Milestone Payments
MilestonePayments
0
roiv Milestone Payments
MilestonePayments
140136000
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
47500000
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
0
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
83679000
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
3615000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
199822000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
roiv Payments Of Subsidiary Dividends
PaymentsOfSubsidiaryDividends
6000000
roiv Payments Of Subsidiary Dividends
PaymentsOfSubsidiaryDividends
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
42142000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
587000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
roiv Payment For Warrant Redemptions
PaymentForWarrantRedemptions
41000
roiv Payment For Warrant Redemptions
PaymentForWarrantRedemptions
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
215349000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
134635000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1571000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-268927000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-461388000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1692115000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2074034000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1423188000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1612646000
roiv Cashless Exercise Of The Company Common Stock Warrants
CashlessExerciseOfTheCompanyCommonStockWarrants
83258000
roiv Cashless Exercise Of The Company Common Stock Warrants
CashlessExerciseOfTheCompanyCommonStockWarrants
0
roiv Common Shares And Other Consideration Issued For Purchase Of Property And Equipment
CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment
0
roiv Common Shares And Other Consideration Issued For Purchase Of Property And Equipment
CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment
9694000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1400000000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4400000000
us-gaap Profit Loss
ProfitLoss
-659000000
us-gaap Profit Loss
ProfitLoss
-669700000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1408231000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1676813000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
5474000
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
5011000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
9483000
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
10291000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1423188000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1692115000
CY2023Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
153052000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12431000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
140621000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4700000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9300000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9300000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9300000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9300000
CY2023Q3 roiv Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
98700000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
60718000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
60827000
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
52118000
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
30379000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
5474000
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
5011000
CY2023Q3 us-gaap Inventory Net
InventoryNet
4905000
CY2023Q1 us-gaap Inventory Net
InventoryNet
2761000
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2506000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2356000
CY2023Q3 roiv Other Of Other Assets Current
OtherOfOtherAssetsCurrent
17675000
CY2023Q1 roiv Other Of Other Assets Current
OtherOfOtherAssetsCurrent
20440000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
143396000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
121774000
CY2023Q3 roiv Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
72554000
CY2023Q1 roiv Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
76278000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30723000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
55186000
CY2023Q3 roiv Accrued Sales Allowances Current
AccruedSalesAllowancesCurrent
18944000
CY2023Q1 roiv Accrued Sales Allowances Current
AccruedSalesAllowancesCurrent
17569000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30702000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18096000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
152923000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
167129000
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5798000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
12444000
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
1358000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
542000
CY2023Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1443000
CY2023Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2090000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8599000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15076000
roiv Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
3
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.011
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.008
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.007
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.009
CY2023Q2 roiv Cashless Public Warrant Exercised
CashlessPublicWarrantExercised
20061507
CY2023Q2 roiv Class Of Warrant Or Right Unexercised Price Of Warrants
ClassOfWarrantOrRightUnexercisedPriceOfWarrants
413971
CY2023Q3 roiv Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.1

Files In Submission

Name View Source Status
0001140361-23-052721-index-headers.html Edgar Link pending
0001140361-23-052721-index.html Edgar Link pending
0001140361-23-052721.txt Edgar Link pending
0001140361-23-052721-xbrl.zip Edgar Link pending
ef20012491_10q.htm Edgar Link pending
ef20012491_ex2-1.htm Edgar Link pending
ef20012491_ex31-1.htm Edgar Link pending
ef20012491_ex31-2.htm Edgar Link pending
ef20012491_ex32-1.htm Edgar Link pending
ef20012491_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
ef20012491_10q_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
roiv-20230930.xsd Edgar Link pending
Show.js Edgar Link pending
roiv-20230930_cal.xml Edgar Link unprocessable
roiv-20230930_pre.xml Edgar Link unprocessable
roiv-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
roiv-20230930_def.xml Edgar Link unprocessable